Sequana Medical Investor Presentation December 2021

Sequana Medical presents its innovative solutions for treating diuretic-resistant fluid overload, including the alfapump® system and DSR® therapy. The presentation covers clinical development, regulatory status, and market opportunity for these novel medical device technologies targeting refractory ascites and fluid management.